These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35020891)

  • 1. Kidney infiltrating NK cells and NK-like T-cells in lupus nephritis: presence, localization, and the effect of immunosuppressive treatment.
    Scheffschick A; Fuchs S; Malmström V; Gunnarsson I; Brauner H
    Clin Exp Immunol; 2022 Apr; 207(2):199-204. PubMed ID: 35020891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Expression pattern of NK cells in systemic lupus erythematosus patients with different disease activities.
    Barakat OM; Badari MS; Elgendy SG; Abdel Hamed MR; Zahran AM; Hassanien MMA; Embarek MS
    Egypt J Immunol; 2024 Oct; 31(4):157-168. PubMed ID: 39427243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation status of CD56
    Liu M; Liu J; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2021 Mar; 40(3):1103-1112. PubMed ID: 32797360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement.
    Liphaus BL; Silva SC; Palmeira P; Silva CA; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Front Immunol; 2024; 15():1327255. PubMed ID: 38562920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
    Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ
    Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus.
    Schepis D; Gunnarsson I; Eloranta ML; Lampa J; Jacobson SH; Kärre K; Berg L
    Immunology; 2009 Jan; 126(1):140-6. PubMed ID: 18564343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression.
    Zahran AM; Abdel-Rahim MH; Elsayh KI; Hassanien MM; Mahran SA; Hetta HF
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):161-169. PubMed ID: 30944972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the CD161-expressing cell quantities and CD161 expression levels in peripheral blood natural killer and T cells of systemic lupus erythematosus patients.
    Lin YL; Lin SC
    Clin Exp Med; 2017 Feb; 17(1):101-109. PubMed ID: 26590595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-γ production by tubulointerstitial human CD56
    Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
    Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased oxidative stress contributes to impaired peripheral CD56
    Lu Z; Tian Y; Bai Z; Liu J; Zhang Y; Qi J; Jin M; Zhu J; Li X
    Arthritis Res Ther; 2022 Feb; 24(1):48. PubMed ID: 35172900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
    Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A
    Front Immunol; 2020; 11():256. PubMed ID: 32265898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis.
    Ramanujam M; Steffgen J; Visvanathan S; Mohan C; Fine JS; Putterman C
    Autoimmun Rev; 2020 Nov; 19(11):102668. PubMed ID: 32942031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of IL-24 in NK cell activation and its clinical implication in systemic lupus erythematosus.
    Tang Y; Sun X; Wang Y; Luan H; Zhang R; Hu F; Sun X; Li X; Guo J
    Clin Rheumatol; 2021 Jul; 40(7):2707-2715. PubMed ID: 33534028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus.
    Hudspeth K; Wang S; Wang J; Rahman S; Smith MA; Casey KA; ; Manna Z; Sanjuan M; Kolbeck R; Hasni S; Ettinger R; Siegel RM
    Clin Exp Immunol; 2019 May; 196(2):226-236. PubMed ID: 30693467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic Function and Cytokine Production of Natural Killer Cells and Natural Killer T-Like Cells in Systemic Lupus Erythematosis Regulation with Interleukin-15.
    Lin SJ; Kuo ML; Hsiao HS; Lee PT; Lee WI; Chen JY; Huang JL
    Mediators Inflamm; 2019; 2019():4236562. PubMed ID: 31049024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and localization of FOXP3 + cells in kidney biopsies in lupus nephritis and ANCA-associated vasculitis.
    Zickert A; Janković MR; Malmström V; Chemin K; Gunnarsson I
    Clin Rheumatol; 2023 Oct; 42(10):2889-2895. PubMed ID: 37368057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.
    Yap DYH; Chan TM
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.
    Henriques A; Teixeira L; Inês L; Carvalheiro T; Gonçalves A; Martinho A; Pais ML; da Silva JA; Paiva A
    Clin Rheumatol; 2013 Jun; 32(6):805-13. PubMed ID: 23377197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal-limited 'lupus-like' nephritis.
    Huerta A; Bomback AS; Liakopoulos V; Palanisamy A; Stokes MB; D'Agati VD; Radhakrishnan J; Markowitz GS; Appel GB
    Nephrol Dial Transplant; 2012 Jun; 27(6):2337-42. PubMed ID: 22207326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis.
    Rafael-Vidal C; Altabás I; Pérez N; Mourino Rodríguez C; Pego-Reigosa JM; Garcia S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33514066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.